284 results on '"Antiparkinson agents -- Reports"'
Search Results
2. New Findings from Northwestern University Feinberg School of Medicine Describe Advances in Parkinson's Disease (a-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson's disease)
3. Researchers from University Medical Center Hamburg-Eppendorf Describe Findings in Dopaminergic Antiparkinsonism Agents (Premotor Cortical Beta Synchronization and the Network Neuromodulation of Externally Paced Finger Tapping In Parkinson's ' S ...)
4. Researchers Submit Patent Application, 'Stabilized Liquid Compositions Comprising A Levodopa-Tyrosine Conjugate And Uses Thereof', for Approval (USPTO 20240207410)
5. Data on Dopaminergic Antiparkinsonism Agents Detailed by a Researcher at David Geffen School of Medicine University of California Los Angeles (UCLA) (Cabergoline Targets Multiple Pathways to Inhibit PRL Secretion and Increases Stromal Fibrosis)
6. Reports Summarize Dopaminergic Antiparkinsonism Agents Findings from Nanchang University [Analysis of Drugs (Apomorphine, Benserazide, Carbidopa), Exercise, Network Pharmacology, Gene Expression, and Molecular Docking As Parkinson's Treatment ...]
7. Research from LMCE Laboratory Has Provided New Study Findings on Chemistry (In Silico Approaches for the Study of New Anti-Parkinson's Agents)
8. Researchers Submit Patent Application, 'Nad-Augmentation Therapy For Parkinson'S Disease', for Approval (USPTO 20240366648)
9. Qatar Foundation Researcher Yields New Study Findings on Personalized Medicine (Immunotherapy for Parkinson's Disease and Alzheimer's Disease: A Promising Disease-Modifying Therapy)
10. Researcher at INTI International University Targets Parkinson's Disease (Literature Review on Acupuncture Treatment for Parkinson's Disease)
11. Research from Jiangsu Institute of Nuclear Medicine Broadens Understanding of Parkinson's Disease (Evaluation of damage discrimination in dopaminergic neurons using dopamine transporter PET tracer [18F]FECNT-d4)
12. Diabetes drug protects against Parkinson's Disease
13. Findings from Zhejiang University School of Medicine Advance Knowledge in Parkinson's Disease (Early-Onset Parkinson's Disease and Brain Iron Accumulation Caused by a Novel Homozygous DJ-1 Mutation)
14. Dankook University Researchers Highlight Recent Research in Dopaminergic Antiparkinsonism Agents (Effect of Dispersion Medium on Pharmacokinetic Profile of Rotigotine Crystalline Suspension following Subcutaneous Injection)
15. Antiepileptic Drugs Tied to Incident Parkinson Disease
16. Findings from Loyola Stritch School of Medicine Advance Knowledge in Parkinson's Disease (Online cognitive testing in Parkinson's disease: advantages and challenges)
17. New Parkinson's Disease Findings from Guangzhou University of Chinese Medicine Described (Efficient Sustained-Release Nanoparticle Delivery System Protects Nigral Neurons in a Toxin Model of Parkinson's Disease)
18. Birla Institute of Technology Researchers Detail Findings in Parkinson's Disease (Food-Grade Quercetin-Loaded Nanoemulsion Ameliorates Effects Associated with Parkinson's Disease and Cancer: Studies Employing a Transgenic * * C. elegans* * ...)
19. Shanxi University Researchers Describe Advances in Parkinson's Disease (Levodopa Improves Behavioral Deficits of Mice with Parkinson's Disease Symptoms via Curbing NLRP3 Inflammasome Activation and Enhancing Tyrosine Hydroxylase Levels in the ...)
20. Findings from University of Strasbourg in the Area of Psychosis Described (From One To Many: Hypertonia In Schizophrenia Spectrum Psychosis an Integrative Review and Adversarial Collaboration Report)
21. Report Summarizes Marine Science and Technology Study Findings from Seoul National University (Tetramic Acid-motif Natural Products From a Marine Fungus tolypocladium Cylindrosporum Fb06 and Their Anti-parkinson Activities)
22. Patent Issued for Targeting adenosine A2A receptors for the treatment of levodopa-induced dyskinesias (USPTO 11246871)
23. Researchers Submit Patent Application, 'Use Of Rasagiline For The Treatment Of Restless Legs Syndrome', for Approval (USPTO 20210386690)
24. Studies in the Area of Parkinson's Disease Reported from Institute for Medical Research and Occupational Health (Selenium Nanoparticles As Potential Drug-delivery Systems for the Treatment of Parkinson's Disease)
25. Studies from University of Toronto Yield New Data on Health and Medicine (Tau In Atypical Parkinsonisms: a Meta-analysis of In Vivo Pet Imaging Findings)
26. Findings from Institute of Pediatrics in Parkinson's Disease Reported (The Positive Role and Mechanism of Herbal Medicine in Parkinson's Disease)
27. Researchers from National Institutes of Health (NIH) Report Details of New Studies and Findings in the Area of Dopaminergic Antiparkinsonism Agents (A Target-agnostic Screen Identifies Approved Drugs To Stabilize the Endoplasmic ...)
28. Research from University of Basilicata Has Provided New Data on Biosensors (An Amperometric Biosensor Based on a Bilayer of Electrodeposited Graphene Oxide and Co-Crosslinked Tyrosinase for L-Dopa Detection in Untreated Human Plasma)
29. Investigators from Hainan University Report New Data on Drug Development (Cysteine [2,4] Disulfide Bond As a New Modifiable Site of Alpha-conotoxin Txib)
30. Researchers Submit Patent Application, 'Use Of Rasagiline For The Treatment Of Restless Legs Syndrome', for Approval (USPTO 20210023026)
31. New Findings from Toronto Western Hospital in the Area of Artificial Intelligence Described (Using Artificial Intelligence To Identify Anti-hypertensives As Possible Disease Modifying Agents In Parkinson's Disease)
32. Findings in Tricyclic Antidepressants Reported from Zagazig University (Non-extractive spectrophotometric determination of memantine HCl, clomipramine HCl and fluvoxamine maleate in pure form and in pharmaceutical products by ion-pair complex ...)
33. Findings from Centre de PharmacoVigilance Provides New Data about Parkinson's Disease (Amiodarone and Parkinsonism: a pharmacovigilance study)
34. New Findings on Parkinson's Disease Described by Investigators at University College London (UCL) (Evaluating Lipid-lowering Drug Targets for Parkinson's Disease Prevention With Mendelian Randomization)
35. New Study Findings from Sungkyunkwan University School of Medicine Illuminate Research in Parkinson's Disease (Novel Nasal Epithelial Cell Markers of Parkinson's Disease Identified Using Cells Treated with a-Synuclein Preformed Fibrils)
36. Study Findings from Department of Experimental and Applied Psychology Broaden Understanding of Dopaminergic Antiparkinsonism Agents (Conscious perception and the modulatory role of dopamine: no effect of the dopamine D2 agonist cabergoline on ...)
37. Patent Issued for Transdermal Drug Delivery System (USPTO 10,576,043)
38. Data on Monoamine Oxidase-B Inhibitors Reported by W.H. Jost and Colleagues (Long-Term Efficacy of Safinamide on Symptoms Severity and Quality of Life in Fluctuating Parkinson's Disease Patients)
39. Researchers at University of Maryland School of Medicine Target Parkinson's Disease (Somatoform Symptoms In Parkinson Disease)
40. Researchers at Affiliated Brain Hospital of Nanjing Medical University Release New Data on Parkinson's Disease (Aberrant inter-network functional connectivity in drug-naive Parkinson's disease patients with tremor dominant and postural ...)
41. Study Findings on Parkinson's Disease Are Outlined in Reports from Tongji University School of Medicine (Parkinson's Disease Gene Biomarkers Screened by the LASSO and SVM Algorithms)
42. Researcher from First Affiliated Hospital of Harbin Medical University Publishes Findings in Parkinson's Disease (Fisetin Ameliorates Levodopa-Induced Dyskinesia in Experimental Model Parkinson's Disease: Role of Mitochondrial Activities and ...)
43. Researchers Submit Patent Application, 'Use Of Rasagiline For The Treatment Of Restless Legs Syndrome', for Approval (USPTO 20190365674)
44. Researchers at University of Hawaii at Manoa Report New Data on Dopaminergic Antiparkinsonism Agents (Rapid and sustained improvement in treatment-refractory depression through use of acute intravenous ketamine and concurrent transdermal ...)
45. Researchers from F. Hoffmann-La Roche Ltd. Describe Findings in Dopaminergic Antiparkinsonism Agents (Treatment Patterns in Patients with Incident Parkinson's Disease in the United States)
46. New Parkinson's Disease Findings from Huazhong University of Science and Technology Outlined (Multiple Pathways for Natural Product Treatment of Parkinson's Disease: a Mini Review)
47. Researchers Submit Patent Application, 'Use Of Rasagiline For The Treatment Of Restless Legs Syndrome', for Approval (USPTO 20190262284)
48. Findings from F. Hoffmann-La Roche Ltd. Has Provided New Information about Dopaminergic Antiparkinsonism Agents (Treatment Patterns in Patients with Incident Parkinson's Disease in the United States)
49. Studies from Janssen Pharmaceutical Companies Add New Findings in the Area of Parkinson's Disease (Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson's Drug Discovery)
50. New Biomolecular Research Findings from University of Wroclaw Described (Effect of phenothiazine compounds on the secondary structure and fibrillogenesis of poly-l-lysine)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.